Gu Juan

Ye Wenqing, Zhang Shaodan, Zhu Shuqing, Li Jinxin, Gu Juan, Zhao Mian et al.

This study found penetrating canaloplasty had similar 2-year success rates and complications to trabeculectomy for primary angle-closure glaucoma, suggesting it's a promising alternative, especially for earlier stages.

Lin Sigeng, Zhang Shaodan, Shang Xiao, Gu Juan, Ye Cong, Wang Xiaoyan et al.

Glaucoma patients with one-sided visual field loss showed faster macular vessel density decline in the affected area, correlating with visual field damage severity, even without significant tissue thinning. This suggests mVD loss is an early, measurable glaucoma progression marker.

Le Rongrong, Xie Yanqian, Cheng Huanhuan, Chen Hong, Ye Wenqing, Deng Yuxuan et al.

Penetrating canaloplasty effectively lowered IOP and medication needs in childhood glaucoma, showing promise as a safe, new treatment option for this challenging condition.

Deng Yuxuan, Zhang Shaodan, Ye Wenqing, Gu Juan, Lin Haishuang, Cheng Huanhuan et al.

Penetrating canaloplasty effectively lowered IOP and medication dependence in glaucoma secondary to iridocorneal endothelial syndrome, offering a promising new treatment option with acceptable complications.

Cheng Huanhuan, Ye Wenqing, Zhang Shaodan, Xie Yanqian, Gu Juan, Le Rongrong et al.

Penetrating canaloplasty effectively lowered IOP and medication dependence in traumatic angle recession glaucoma, showing high 1-year success, offering a promising treatment option.

Zhang Shaodan, Hu Cheng, Cheng Huanhuan, Gu Juan, Samuel Kwizera, Lin Haishuang et al.

Penetrating canaloplasty effectively lowered IOP and medication dependence in severe primary angle-closure glaucoma, offering a promising bleb-independent surgical option for these challenging cases.